Welcome to our dedicated page for Costas news (Ticker: CSSI), a resource for investors and traders seeking the latest updates and insights on Costas stock.
Standard Dental Labs, Inc. (CSSI) delivers advanced dental laboratory solutions through strategic acquisitions and rigorous compliance with industry standards. This news hub provides investors and dental professionals with timely updates on the company's operational milestones, financial strategies, and market expansions.
Access centralized updates on CSSI's key developments, including earnings reports, regulatory achievements, and technology integrations. Our curated news collection ensures stakeholders stay informed about initiatives like FINRA compliance efforts and growth in Florida's dental market.
Explore comprehensive coverage of CSSI's business activities, from corporate governance enhancements to innovative dental lab services. Regular updates include analysis of strategic moves such as Tier 2 Regulation A offerings and operational optimizations that reinforce market positioning.
Bookmark this page for direct access to CSSI's evolving story in the dental industry. Check back frequently for unbiased reporting on acquisitions, compliance updates, and technological advancements shaping the future of dental laboratory solutions.
Standard Dental Labs (formerly Costas Inc.) announced FINRA's approval of its name change and ticker symbol transition from 'CSSI' to 'TUTH'. The company will implement a 20:1 reverse stock split effective March 13, 2025, with split-adjusted trading beginning March 14, 2025.
The stock will temporarily trade as 'CSSID' for 20 business days before changing to 'TUTH' around April 10, 2025. The company's outstanding shares will decrease from approximately 572,206,363 to 28,610,318 post-split. The authorized capital remains at 2 billion shares.
All fractional shares will be rounded up, and existing securities (options, warrants, preferred stock, convertible notes) will be adjusted according to the 20:1 ratio. Transfer Online Inc. will manage the exchange process, with stockholders not required to exchange existing certificates.
Standard Dental Labs (OTCMKTS: CSSI) has filed its 2024 Annual Report and Audited Financial Statements for the fiscal year ending December 31, 2024. The company reported:
- Negative revenue growth despite expansion focus
- Ongoing acquisition strategy targeting dental labs in Florida
- Maintained compliance with FINRA and SEC requirements
CEO James Brooks emphasized the company's efforts to strengthen its financial position and expand its footprint through strategic acquisitions and operational efficiencies. The complete annual report and financial statements are accessible through the company's website and OTC Markets disclosure portal.
Standard Dental Labs (OTCMKTS: CSSI) has shared insights on emerging trends in the dental prosthetics industry, highlighting key market shifts toward digital dentistry, automation, and patient-specific customization. The company reported significant investments in 2024, including upgrades to all 3D tooling, state-of-the-art 3D milling equipment, medical-grade compressors, and advanced air filtration systems.
The company is pursuing a measured expansion strategy, focusing on integrating private dental labs in Florida while maintaining quality and service consistency. Their approach emphasizes smart implementation of technology to enhance operational efficiencies without compromising craftsmanship.
Key industry trends identified include:
- Digital Workflows & CAD/CAM Technology adoption
- AI & Automation implementation in case planning and fabrication
- Growing demand for customized, high-quality prosthetic solutions
Standard Dental Labs (OTCMKTS: CSSI) announces two significant developments: near completion of FINRA compliance process and filing of a Tier 2 Regulation A offering. The company has worked with FINRA since March to restore compliance standing, demonstrating commitment to regulatory integrity. The Tier 2 offering, allowing up to $75 million in fundraising over 12 months, aims to address cash flow needs and support expansion in Florida's dental lab market.
CEO James Brooks highlighted these achievements as important milestones following three quarters of addressing operational and financial challenges. The company has collaborated with the SEC, securities counsel, CPAs, and auditors to ensure financial diligence while pursuing its strategy to acquire additional dental laboratories in Florida.
Costas, Inc. (CSSI), operating as Standard Dental Labs, is actively pursuing acquisitions of dental labs in Orlando following its successful acquisition of Prime Dental Lab in August 2022. With an aim to consolidate these facilities into a "Mega Lab," the company has resumed discussions with interested lab owners. Recent communications indicate that five additional lab owners are eager to negotiate with Standard Dental Labs. CEO James Brooks highlights the opportunity presented by retiring baby boomers, stating that many own dental labs. The strategic goal is to grow through acquisitions and expand revenue in the increasingly consolidating dental industry.
ORLANDO, FL / ACCESSWIRE / January 31, 2023 / Costas, Inc. (OTC PINK:CSSI) reflects on 2022 milestones post-CEO James Brooks' appointment. Key achievements include acquiring assets from Standard Dental Labs in March 2022, establishing a focus on acquiring cash-flowing dental labs, and generating its first revenue in 20 years following the Prime Dental Lab acquisition. The dental lab market is valued at $10B in the U.S., and CSSI aims to purchase up to 20 labs in 2023. The company plans to consolidate operations in Orlando, ensuring future revenue growth while emphasizing the need for a strong management team to support its expansion strategy.
FAQ
What is the current stock price of Costas (CSSI)?
What is the market cap of Costas (CSSI)?
